{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:33:28Z","timestamp":1792740808655,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T00:00:00Z","timestamp":1369267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00415-013-6957-4","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T03:24:16Z","timestamp":1369193056000},"page":"17-26","source":"Crossref","is-referenced-by-count":112,"title":["Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported"],"prefix":"10.1007","volume":"261","author":[{"given":"Axel","family":"Petzold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon T.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,23]]},"reference":[{"key":"6957_CR1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","volume":"126","author":"D Kidd","year":"2003","unstructured":"Kidd D, Burton B, Plant GT, Graham EM (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126:276\u2013284","journal-title":"Brain"},{"key":"6957_CR2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker B G (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u201312","journal-title":"Lancet"},{"issue":"23","key":"6957_CR3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70(23):2197\u201320","journal-title":"Neurology"},{"issue":"1","key":"6957_CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","volume":"81","author":"A Petzold","year":"2010","unstructured":"Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT (2010) Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune-mediated optic neuritis. J Neurol Neurosurg Psychiatry 81(1):109\u2013111","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"(1-2)","key":"6957_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","volume":"298","author":"S Jarius","year":"2010","unstructured":"Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R, Franciotta D, Ruprecht K, Kuenz B, Rommer P, Kristoferitsch W, Wildemann B, Vincent A (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298(1-2):158\u2013162","journal-title":"J Neurol Sci"},{"issue":"1","key":"6957_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Munch C, Winkelmann A, Zettl UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 9(1):14","journal-title":"J Neuroinflammation"},{"issue":"5","key":"6957_CR7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/WNR.0b013e32832776f4","volume":"20","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita M, Nakatsuji Y, Moriya M, Okuno T, Kumanogoh A, Nakano M, Takahashi T, Fujihara K, Tanaka K, Sakoda S (2009) Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport 20(5):508\u2013512","journal-title":"Neuroreport"},{"key":"6957_CR8","doi-asserted-by":"crossref","unstructured":"Sabater L, Giralt A, Boronat A, Hankiewicz K, Blanco Y, Llufriu S, Alberch J, Graus F, Saiz A (2009) Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study. J Neuroimmunol 215(1\u20132):31\u201335","DOI":"10.1016\/j.jneuroim.2009.07.014"},{"key":"6957_CR9","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/brain\/awf165","volume":"125","author":"A Petzold","year":"2002","unstructured":"Petzold A, Eikelenboom MJ, Gveric D, Keir G, Chapman M, Lazeron RH et\u00a0al (2002) Markers for different glial cell responses in multiple sclerosis: Clinical and pathological correlations. Brain 125:1462\u20131473","journal-title":"Brain"},{"issue":"12","key":"6957_CR10","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","volume":"61","author":"C Malmestroem","year":"2003","unstructured":"Malmestroem C, Haghighi S, Rosengren L, Andersen O, Lycke J (2003) Neurofilament light protein and glial fibrillary acidic protein as biological markers in ms. Neurology 61(12):1720\u20131725","journal-title":"Neurology"},{"issue":"5","key":"6957_CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","volume":"80","author":"T Misu","year":"2009","unstructured":"Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y (2009) Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry 80(5):575\u2013577","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"6957_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp.2009.196550","volume":"82","author":"A Petzold","year":"2011","unstructured":"Petzold A, Marignier R, Verbeek MM, Confavreux C (2011) Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? preliminary results on 188 patients with different neurological diseases. J Neurol Neurosurg Psychiatry 82(4):467\u2013469","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"6957_CR13","doi-asserted-by":"crossref","first-page":"e23489","DOI":"10.1371\/journal.pone.0023489","volume":"6","author":"M Storoni","year":"2011","unstructured":"Storoni M, Petzold A, Plant GT (2011) The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis. PLoS One, 6(8):e23489","journal-title":"PLoS One"},{"issue":"1\u20132","key":"6957_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.02.012","volume":"317","author":"M Storoni","year":"2012","unstructured":"Storoni M, Verbeek MM, Illes Z, Marignier R, Teunissen CE, Grabowska M, Confavreux C, Plant GT, Petzold A (2012) Serum GFAP levels in optic neuropathies. J Neurol Sci 317(1\u20132):117\u2013122","journal-title":"J Neurol Sci"},{"key":"6957_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/01658100500218053","volume":"29","author":"L Benito De","year":"2005","unstructured":"De Benito L, Mu\u00f1oz L, Mart\u00ednez M, Cort\u00e9s C, De Andr\u00e9s C (2005) Recurrent bilateral inflammatory idiopathic optic neuropathy treated with mycophenolate mofetil: clinical and radiological course. Neuroophthalmology 29:149\u2013159","journal-title":"Neuroophthalmology"},{"key":"6957_CR16","doi-asserted-by":"crossref","first-page":"s248","DOI":"10.1111\/j.1755-3768.2009.01661.x","volume":"89","author":"R Herrero Latorre","year":"2011","unstructured":"Herrero Latorre R, Fernandez Perez S, De La Mata G, Idoipe M, Satue M, Garcia Martin E (2011) A case of chronic relapsing inflammatory optic neuropathy (CRION). Acta Ophthalmologica 89:s248","journal-title":"Acta Ophthalmologica"},{"issue":"6","key":"6957_CR17","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ajo.2005.06.053","volume":"140","author":"D Kurz","year":"2005","unstructured":"Kurz D, Egan RA, Rosenbaum JT (2005) Treatment of corticosteroid dependent optic neuropathy with intravenous immunoglobulin. Am J Ophthalmol 140(6):1132\u20131133","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"6957_CR18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00415-008-0919-2","volume":"255","author":"O Kaut","year":"2008","unstructured":"Kaut O, Klockgether T (2008) 51-year-old female with steroid-responsive optic neuropathy: a new case of chronic relapsing inflammatory optic neuropathy (CRION). J Neurol 255(9):1419\u20131420","journal-title":"J Neurol"},{"key":"6957_CR19","first-page":"815068","volume":"2011","author":"GT Plant","year":"2011","unstructured":"Plant GT, Sibtain NA, Thomas D (2011) Hyperacute corticosteroid treatment of optic neuritis at the onset of pain may prevent visual loss: a case series. Mult Scler Int 2011:815068","journal-title":"Mult Scler Int"},{"issue":"8","key":"6957_CR20","first-page":"553","volume":"22","author":"H P\u00e9rez-D\u00edaz","year":"2007","unstructured":"P\u00e9rez-D\u00edaz H, Casado JL, Ucl\u00e9s-S\u00e1nchez A, Saiz A (2007) Chronic relapsing inflammatory optic neuropathy (CRION) without detection of IgG-NMO antibodies. Neurologia 22(8):553\u2013555","journal-title":"Neurologia"},{"issue":"6","key":"6957_CR21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bjo.2006.111666","volume":"92","author":"C Prendiville","year":"2008","unstructured":"Prendiville C, O\u2019Doherty M, Moriarty P, Cassidy L (2008) The use of infliximab in ocular inflammation. Br J Ophthalmol 92(6):823\u2013825","journal-title":"Br J Ophthalmol"},{"key":"6957_CR22","first-page":"93","volume":"22","author":"C Ramos Fern\u00e1ndez","year":"2011","unstructured":"Ramos Fern\u00e1ndez C, Garc\u00eda Oliva I, Reyes Rodr\u00edguez MA, Francisco Hern\u00e1ndez F, Tand\u00f3n C\u00e1rdenes L, Gonz\u00e1lez Hern\u00e1ndez A (2011) Neuropat\u00eda\u00f3ptica inflamatoria recurrente cr\u00f3nica (CRION): a prop\u00f3sito de un caso. Archivos de la Sociedad Canaria de Oftalmolog\u00eda 22:93\u201398","journal-title":"Archivos de la Sociedad Canaria de Oftalmolog\u00eda"},{"issue":"1","key":"6957_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0972-2327.61280","volume":"13","author":"M Saini","year":"2010","unstructured":"Saini M, Khurana D (2010) Chronic relapsing inflammatory optic neuropathy. Ann Indian Acad Neurol 13(1):61\u201363","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"6957_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1752-1947-6-15","volume":"6","author":"A Samra","year":"2012","unstructured":"Samra A, Ramtahal J (2012) Recurrent subacute visual loss presenting in a 52-year-old Caucasian woman with chronic relapsing inflammatory optic neuropathy: a case report. J Med Case Rep 6(1):15","journal-title":"J Med Case Rep"},{"key":"6957_CR25","doi-asserted-by":"crossref","unstructured":"Kubrak M, Czajor K, Turno-Krecicka A (2012) A 45-year-old woman with sudden loss of vision a case report. Neuro-ophthalmology, 36(S1):30, Abstracts of the 2012 Meeting of the International Neuro-Ophthalmology Society, Singapore","DOI":"10.3109\/01658107.2012.690640"},{"issue":"1","key":"6957_CR26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3129\/i09-238","volume":"45","author":"H Stiebel-Kalish","year":"2010","unstructured":"Stiebel-Kalish H, Hammel N, van Everdingen J, Huna-Baron R, Lee AG (2010) Intravenous immunoglobulin in recurrent-relapsing inflammatory optic neuropathy. Can J Ophthalmol 45(1):71\u201375","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"6957_CR27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajo.2006.11.022","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Wittenberg S, Kedhar SR, Dunn JP, Jabs DA (2007) Optic neuropathy complicating multifocal choroiditis and panuveitis. Am J Ophthalmol 143(4):721\u2013723","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"6957_CR28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0028-3886.103186","volume":"60","author":"L Pandit","year":"2012","unstructured":"Pandit L, Shetty R, Misri Z, Bhat S, Amin H, Pai V, Rao R (2012) Optic neuritis: experience from a south Indian demyelinating disease registry. Neurol India 60(5):470\u2013475","journal-title":"Neurol India"},{"key":"6957_CR29","first-page":"15","volume":"2","author":"A Kurne","year":"2010","unstructured":"Kurne A, Krabudak R, Cakmakli GY et\u00a0al (2010) Recurrent optic neuritis: clues from a long-term follow-up study of recurrent and bilateral optic neuritis patients. Eye Brain 2:15\u201320","journal-title":"Eye Brain"},{"key":"6957_CR30","unstructured":"Wiryasaputra S, Lim SA (2010) Relationship between visual acuity, visual field and retinal nerve fibre layer thickness in optic neuritis. In: INOS, p 46. Tan Tock Seng Hospital, Singapore"},{"key":"6957_CR31","doi-asserted-by":"crossref","unstructured":"Benoilid A, Tilikete C, Arndt C, Collengues N, Vignal-Clermont C, Vighetto A, De Seze J (2012) Relapsing inflammatory optic neuropathy: a multicenter study of 62 patients. Neurology, 78:p 07.251, Abstract, American Academy of Neurology","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P07.251"},{"key":"6957_CR32","unstructured":"Palmi-Cortes I, Meca-Lallana V, Canneti B, Valenzuela-Rojas FJ, Vivancos J (2012) Recurrent optic neuritis: the importance of the differential diagnosis. Mult Scler p 215, Abstract ECTRIMS"},{"key":"6957_CR33","unstructured":"Falcao B, Bichuetti DB, Oliveira EML, Nmo GAA (2012) CRION or MS: what we say when we have recurrent optic neuritis. Mult Scler p 604, Abstract. ECTRIMS"},{"key":"6957_CR34","doi-asserted-by":"crossref","unstructured":"Wong S, Cleary G, Graham EM, Plant GT (2012) Blindness cured: response to late steroids in. J Neurol Neurosurg Psychiatry 83:A28, Abstract. ABN","DOI":"10.1136\/jnnp-2012-304200a.103"},{"issue":"5","key":"6957_CR35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bjo.2003.028472","volume":"88","author":"TD Myers","year":"2004","unstructured":"Myers TD, Smith JR, Wertheim MS, Egan RA, Shults WT, Rosenbaum JT (2004) Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid-dependent optic neuritis not associated with demyelinating disease. Br J Ophthalmol 88(5):673\u2013680","journal-title":"Br J Ophthalmol"},{"issue":"1\u20132","key":"6957_CR36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2011.08.030","volume":"312","author":"M Storoni","year":"2012","unstructured":"Storoni M, Pittock SJ, Weinshenker BG, Plant GT (2012) Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage. J Neurol Sci 312(1\u20132):21\u201325","journal-title":"J Neurol Sci"},{"issue":"9","key":"6957_CR37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. the optic neuritis study group. N Engl J Med 326(9):581\u2013588","journal-title":"N Engl J Med,"},{"issue":"6","key":"6957_CR38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","volume":"115","author":"Optic Neuritis Study Group","year":"2008","unstructured":"Optic Neuritis Study Group (2008) Visual function 15\u00a0years after optic neuritis: a final follow-up report from the optic neuritis treatment trial. Ophthalmology 115(6):1079\u20131082","journal-title":"Ophthalmology"},{"issue":"7","key":"6957_CR39","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archneur.1991.00530190096021","volume":"48","author":"FE Lepore","year":"1991","unstructured":"Lepore FE (1991) The origin of pain in optic neuritis. Determinants of pain in 101 eyes with optic neuritis. Arch Neurol 48(7):748\u2013749","journal-title":"Arch Neurol"},{"key":"6957_CR40","first-page":"372361","volume":"2012","author":"E Thouvenot","year":"2012","unstructured":"Thouvenot E, Mura F, De Verdal M, Carlander B, Charif M, Schneider C, Navarre S, Camu W (2012) Ipsilateral uveitis and optic neuritis in multiple sclerosis. Mult Scler Int 2012:372361","journal-title":"Mult Scler Int"},{"issue":"9","key":"6957_CR41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ (2012) Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78(9):665\u2013671","journal-title":"Neurology"},{"key":"6957_CR42","first-page":"217802","volume":"2012","author":"A Petzold","year":"2012","unstructured":"Petzold A, Plant GT (2012) The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies. Mult Scler Int 2012:217802","journal-title":"Mult Scler Int"},{"key":"6957_CR43","doi-asserted-by":"crossref","unstructured":"Stangel M, Fredrikson S, Meinl E, Petzold A, Stve O, Tumani H (2013) The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nat Rev Neurol 9(5):267\u2013276","DOI":"10.1038\/nrneurol.2013.41"},{"issue":"2","key":"6957_CR44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"4","key":"6957_CR45","doi-asserted-by":"crossref","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S, Petzold A (2012) The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment. PLoS One 7(4):e34823","journal-title":"PLoS One"},{"key":"6957_CR46","doi-asserted-by":"crossref","unstructured":"Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135(6):1786\u20131793","DOI":"10.1093\/brain\/aws098"},{"issue":"Pt 12","key":"6957_CR47","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1093\/brain\/aws216","volume":"135","author":"LJ Balk","year":"2012","unstructured":"Balk LJ, Killestein J, Polman CH, Uitdehaag BMJ, Petzold A (2012) Microcystic macular oedema confirmed, but not specific for multiple sclerosis. Brain 135(Pt 12):e226","journal-title":"Brain"},{"issue":"11","key":"6957_CR48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1474-4422(12)70231-4","volume":"11","author":"A Petzold","year":"2012","unstructured":"Petzold A (2012) Microcystic macular oedema in ms: T2 lesion or black hole. Lancet Neurol 11(11):933\u2013934","journal-title":"Lancet Neurol"},{"key":"6957_CR49","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","volume":"360","author":"SJ Hickman","year":"2002","unstructured":"Hickman SJ, Dalton CM, Miller DH, Plant GT (2002) Management of acute optic neuritis. Lancet 360:1953\u20131962","journal-title":"Lancet"},{"key":"6957_CR50","first-page":"1409","volume":"4","author":"J Graves","year":"2010","unstructured":"Graves J, Balcer LJ (2010) Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol 4:1409\u20131422","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"6957_CR51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.autrev.2011.05.008","volume":"11","author":"UK Zettl","year":"2010","unstructured":"Zettl UK, Stve O, Patejdl R (2010) Immune-mediated CNS diseases: a review on nosological classification and clinical features. Autoimmun Rev 11(3):167\u2013173","journal-title":"Autoimmun Rev"},{"issue":"5","key":"6957_CR52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.autrev.2012.12.002","volume":"12","author":"LPC Seguro","year":"2013","unstructured":"Seguro LPC, Rosario C, Shoenfeld Y (2013) Long-term complications of past glucocorticoid use. Autoimmun Rev 12(5):629\u2013632","journal-title":"Autoimmun Rev"},{"issue":"Pt 12","key":"6957_CR53","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1093\/brain\/awm283","volume":"130","author":"J Gijn van","year":"2007","unstructured":"van Gijn J (2007) Cerebral vasoconstriction, headache and sometimes stroke: one syndrome or many? Brain 130(Pt 12):3060\u20133062","journal-title":"Brain"},{"issue":"2","key":"6957_CR54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/WNO.0b013e31825662f1","volume":"32","author":"MJ Morrow","year":"2012","unstructured":"Morrow MJ, Wingerchuk D (2012) Neuromyelitis optica. J Neuroophthalmol 32(2):154\u2013166","journal-title":"J Neuroophthalmol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-6957-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-6957-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-6957-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T21:19:47Z","timestamp":1563052787000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-6957-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,23]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["6957"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-6957-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718018127.793478093","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,23]]}}}